Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The investigators are selecting sixty (60) with breast cancer diagnoses where the surgical treatment is indicated.Furthermore the investigators divided in two groups : 1) surgical treatment using regular electric scalpel ; 2) surgical treatment using argon plasma coagulation scalpel. Our primary goal is to measure the bleeding during the surgery using the weight of the surgical tissues used. Secondary we'll evaluate the immediate post operative outcomes, like infection, hematomas and seromas. All these variables will be evaluated by a doctor using our standard clinical record and it will be measured using reliable parameters, for exemple: if the investigators clinically detect a hematoma then we'll perform an ultrasound to take the real extension; if the investigators clinically pick an infection we'll measure the extension of the hiperemia; and if the investigators clinically pick a seroma we'll drain and quantify it. Secondary the investigators going to evaluate and measure (centimeters) the terminal damage caused on the surgical specimens (samples) using the microscope.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Sep 2014
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 28, 2015
CompletedFirst Posted
Study publicly available on registry
September 14, 2015
CompletedSeptember 14, 2015
August 1, 2015
2 months
July 28, 2015
September 11, 2015
Conditions
Outcome Measures
Primary Outcomes (2)
intra-operative outcomes
evaluate the bleeding during the surgery using weight of the surgical tissues used during the procedure.
surgery duration
post operative outcomes
evaluate the occurrence of hematomas, seromas and infection using our clinical record as standard evaluation and measure it when it's possible ( like explained on the brief comments.
30 days
Secondary Outcomes (1)
margin damage
during the surgery
Study Arms (2)
electric scalpel (ES)
OTHERBreast surgery is performed using regular electric scalpel
argon plasma coagulation (APC)
OTHERBreast surgery is performed using argon plasma coagulation scalpel
Interventions
On the first group we use the regular electric scalpel to perform the surgery , and on the second group we use the argon plasma coagulation scalpel to perform the procedure.
Eligibility Criteria
You may qualify if:
- operable breast cancer
You may not qualify if:
- coagulation disturbs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 28, 2015
First Posted
September 14, 2015
Study Start
September 1, 2014
Primary Completion
November 1, 2014
Study Completion
April 1, 2015
Last Updated
September 14, 2015
Record last verified: 2015-08